BioDlink Biopharm Co.,Ltd
- CMO, CRO
BioDlink BioPharm is a fully integrated CDMO offering end-to-end biologics development and manufacturing services. Backed by U.S. and Taiwan investments and listed on the HKEX since 2019, BioDlink has hands-on experience across the full drug development lifecycle—from early-stage R&D to commercial production. Technical expertise spans mAbs, bispecifics, fusion proteins, ADCs, and other bioconjugates. The company is strong in troubleshooting capabilities and a robust quality system compliant with US, EU, and China regulatory standards.